Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 7/20 | 0.65 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.65 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.65 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.65 |
| ▸ | CHRNB1 | P11230 | 4/20 | 0.65 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.65 |
| ▸ | CHRNB3 | Q05901 | 3/20 | 0.65 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.65 |
| ▸ | CHRNG | P07510 | 1/20 | 0.52 |
| ▸ | CHRND | Q07001 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7374508 | 1.00 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| SCHEMBL155343 | 1.00 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| SCHEMBL155974 | 1.00 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| SCHEMBL8435282 | 1.00 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL7465854 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL7411186 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL8437416 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL7463132 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL8438541 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 | |
| Hydrochloric Acid SCHEMBL7463126 | 0.99 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0663912-B1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LAB (US) | 2001-12-12 | — | — | EP | claimed |
| US-5914328-A | CONTROL DOPAMINE RELEASE, ACTIVATE CHOLINERGIC CHANNELS | ABBOTT LABORATORIES (US) | 1999-06-22 | — | — | US | claimed |
| EP-0663912-A1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LABORATORIES (US) | 1995-07-26 | — | — | EP | claimed |
| EP-0663912-A4 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION. | ABBOTT LAB (US) | 1995-02-17 | — | — | EP | claimed |
| WO-1994008992-A1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LABORATORIES (US) | 1994-04-28 | — | — | WO | claimed |
| EP-0663912-B1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LAB (US) | 2001-12-12 | — | — | EP | disclosed |
| US-5948793-A | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release | ABBOTT LABORATORIES (US) | 1999-09-07 | — | — | US | disclosed |
| US-5914328-A | CONTROL DOPAMINE RELEASE, ACTIVATE CHOLINERGIC CHANNELS | ABBOTT LABORATORIES (US) | 1999-06-22 | — | — | US | disclosed |
| EP-0663912-A1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LABORATORIES (US) | 1995-07-26 | — | — | EP | disclosed |
| EP-0663912-A4 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION. | ABBOTT LAB (US) | 1995-02-17 | — | — | EP | disclosed |
| WO-1994008992-A1 | HETEROCYCLIC ETHER COMPOUNDS THAT ENHANCE COGNITIVE FUNCTION | ABBOTT LABORATORIES (US) | 1994-04-28 | — | — | WO | disclosed |